EUVIMEDEUVIMED entdecken
Crossref

Symptom burden and outcomes among patients with early-onset versus average-onset neuroendocrine neoplasms

Suriya Baskar, Rishi R Patel, Brandon Rose, Sawyer Bawek, Ashish Samaddar, Tao Xu, Michael O'Rorke, Deepak Vadehera, Timothy J Brown, Nicholas Hornstein, Udhayvir Singh Grewal

Supportive Care in Cancer · 2026-07 · 34 (7)

DOI: 10.1007/s00520-026-10919-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 25.06.2026. Verfasst von Suriya Baskar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Brooklyn Hospital Center, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Hospitalization. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence of neuroendocrine neoplasms (NENs) is rising, particularly among younger patients, but data comparing early-onset (EO-NENs) and average-onset (AO-NENs) remain limited. Using the National Inpatient Sample (2016-2020), we compared patient characteristics, symptom burden, and outcomes between these groups. METHODS: Hospitalizations with NENs were identified using ICD-10 codes and stratified as EO (< 50 years) or AO (≥ 50 years). Demographics, comorbidities, symptom burden, interventions, and outcomes were compared using t-tests, chi-squared tests, and logistic regression analysis (p < 0.001 significant because of Bonferroni correction). RESULTS: We identified 22,555 EO-NEN and 149,470 AO-NEN hospitalizations. EO-NEN patients were more often female (55% vs. 49%). Private insurance was more common in EO-NENs (59% vs. 28%, p < 0.001). EO-NENs were more frequently intestinal or thymic in origin. Symptom burden was higher in EO-NENs, including nausea/vomiting (8.6% vs. 4.7%), constipation (13.9% vs. 10.8%), abdominal pain (1.9% vs. 1.3%), and anxiety (18.3% vs. 14.0%; all p < 0.001). AO-NENs experienced more acute complications (heart failure, cardiac arrest). Multivariate analysis showed no significant difference in odds of inpatient mortality between both cohorts. EO-NEN hospitalizations had higher rates of treatment with chemotherapy (6.1% vs. 4.2%) and surgical resection. CONCLUSIONS: EO-NENs represent a clinically distinct subset with greater symptom burden but fewer acute complications and similar mortality compared to AO-NENs. These findings highlight the need for age-tailored care pathways and further research into the unique biology driving EO-NENs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsHospitalizationHumansFemaleSymptom BurdenMiddle AgedAge of OnsetMaleAdultAgedUnited StatesAge FactorsYoung AdultIncidenceLogistic Models

Stichwörter der Autor:innen

Early-onsetNeuroendocrine neoplasmsNeuroendocrine tumorsSymptom burden

Autor:innen und Institutionen

  • Department of Internal Medicine, Brooklyn Hospital Center, Brooklyn, NY, USA.
  • Department of Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Division of Hematology and Oncology, Department of Medicine, University of Texas Medical Center, Dallas, TX, USA.
  • Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.
  • Department of Hematology and Oncology, Northwell Health, New York, NY, USA.
  • College of Public Health, University of Iowa, Iowa City, IA, USA.

Zitieren

APA

Baskar, S., Patel, R. R., Rose, B., Bawek, S., Samaddar, A., Xu, T., O'Rorke, M., Vadehera, D., Brown, T. J., Hornstein, N., & Grewal, U. S. (2026). Symptom burden and outcomes among patients with early-onset versus average-onset neuroendocrine neoplasms. Supportive Care in Cancer, 34(7). https://doi.org/10.1007/s00520-026-10919-0

Vancouver

Baskar S, Patel RR, Rose B, Bawek S, Samaddar A, Xu T, et al. Symptom burden and outcomes among patients with early-onset versus average-onset neuroendocrine neoplasms. Supportive Care in Cancer. 2026;34(7). doi:10.1007/s00520-026-10919-0

BibTeX
@article{Baskar2026,
  author = {Baskar, Suriya and Patel, Rishi R and Rose, Brandon and Bawek, Sawyer and Samaddar, Ashish and Xu, Tao and O'Rorke, Michael and Vadehera, Deepak and Brown, Timothy J and Hornstein, Nicholas and Grewal, Udhayvir Singh},
  title = {Symptom burden and outcomes among patients with early-onset versus average-onset neuroendocrine neoplasms},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {7},
  doi = {10.1007/s00520-026-10919-0}
}
Kostenlos starten →